FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions relates to medicine, namely to pharmacology and virology, and can be used for the prevention and treatment of viral infections, caused by RNA viruses with a negative chain, preferably flu viruses, first of all, viruses of H5 or H7 types. For this purpose a composition, containing a salt of o-acetylsalicylic acid with amino acid, selected from the group, including lysine, arginine, ornithine, diaminobutyric acid and a mixture of the said amino acids, is claimed. Also claimed is a method of applying an aerosol composition, which includes a salt of o-acetylsalicylic acid with natural or non-natural basic amino acid, a propellant and an optionally auxiliary substance and/or a carrier. The method involves aerogenic introduction of a physiologically active amount of the said aerosol composition to a person who is at risk of a viral infection or already infected by it, by inhalation through the nose or mouth.
EFFECT: inventions provide a possibility of efficient prevention and treatment of the said viral infections with good tolerability of the introduced preparation form and an absence of risk of asthma attack development.
12 cl, 12 dwg, 7 ex
Title | Year | Author | Number |
---|---|---|---|
NEW PROTEINS H5, MOLECULES OF NUCLEIC ACIDS THAT CODE THEM AND VECTORS, AND THEIR APPLICATION IN MEDICINE | 2007 |
|
RU2479589C2 |
EMULSION PREPARATION FOR PROPHYLAXIS OF RESPIRATORY VIRAL INFECTIONS | 2001 |
|
RU2189231C1 |
ANTIVIRAL PHARMACEUTICAL COMPOSITION CONTAINING FAVIPIRAVIR AND AN AMINO ACID, MEDICINAL PRODUCT CONTAINING SAID COMPOSITION, AND APPLICATION THEREOF FOR TREATING AND/OR PREVENTING VIRAL INFECTIONS | 2021 |
|
RU2783282C1 |
ANTIVIRAL PHARMACEUTICAL COMPOSITION CONTAINING FAVIPIRAVIR AND AMINO ACID, DRUG CONTAINING IT, AS WELL AS THEIR USE FOR TREATING AND/OR PREVENTING VIRAL INFECTIONS | 2022 |
|
RU2814927C1 |
COMPUTER-OPTIMIZED ANTIGENS WITH WIDE REACTIVITY SPECTRUM FOR INFLUENZA VIRUSES OF H5N1 AND H1N1 | 2013 |
|
RU2639551C2 |
METHOD TO APPLY MODIFIED FLU VIRUS | 2006 |
|
RU2480480C2 |
MODIFIED INFLUENZA VIRUS FOR MONITORING AND INCREASING VACCINE EFFICACY | 2006 |
|
RU2420535C2 |
COMPOSITION CONTAINING PEPTIDE AND VIRUS NEURAMINIDASE INHIBITOR | 2011 |
|
RU2596785C2 |
MODIFIED INFLUENZA VIRUS VACCINES | 2013 |
|
RU2552213C2 |
INFLUENZA VACCINE | 2011 |
|
RU2583297C2 |
Authors
Dates
2014-07-27—Published
2009-01-14—Filed